Moo J Cho

PhD, Associate Professor, UNC-Chapel Hill, Molecular Therapeutics

Moo J Cho

PhD
Associate Professor
UNC-Chapel Hill
Molecular Therapeutics
1308 Kerr Hall Chapel Hill
919-966-1345

Related Website

Area of interest

CYTOSOLIC DELIVERY OF NUCELIC ACIDS
This research focuses on possible means of endosome-to-cytosol transfer of antisense oligonucleotides and siRNA. The working hypothesis behind the approach is based on the acidity and reductive environment of endosomes.

SYSEMIC DELIVERY OF CpG OLIGONUCLEOTIDES
Cancer immunotherapy with CpG oligos requires a conventional systemic route of administration. Our approach exploits use of endogenous anti-Gal antibodies as galactosylated CpG oligos or pre-made monovalent immune complexes for IV or SC route of administration.

A THIRD GENERATION PACLITAXEL FORMULATION
Our target drug concentration is 10 to 25 mg/ml. Upon IV administration, the drug should demonstrate a prolonged circulatory half-life, days in mice. In tumor bearing mice, our target delivery is 15-25 % injected dose per 100-200 mm3 tumor. The approach is based on exploiting a naturally occurring endogenous carrier.

Link to Publications on Reach NC site

Filed under: